Physician profile
Tsauyu Lin
NPI 1477527331
$2,517.84
in general payments reported to CMS, 2019-2025
17 companies · $370 in 2025
The $370 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $283 · 2021: $212 · 2022: $369 · 2023: $245 · 2024: $282 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $897.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,397.19 | 2019-2025 | |
| Janssen Biotech, INC. | $197.81 | 2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $188.60 | 2019-2024 | Entyvio, Eohilia |
| Medtronic, INC. | $159.64 | 2022-2025 | Endoflip |
| Qol Medical, LLC | $114.80 | 2019-2024 | Sucraid, Sucraid |
| Allergan, INC. | $76.63 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.53 | 2019-2021 | |
| Gilead Sciences, INC. | $65.99 | 2023-2024 | |
| Covidien LP | $61.31 | 2019 | |
| Shionogi INC | $31.84 | 2020 | |
| Merck Sharp & Dohme LLC | $31.68 | 2019-2024 | Dificid |
| Genzyme Corporation | $30.79 | 2023 | |
| Braintree Laboratories, INC. | $27.50 | 2019 | |
| Ironwood Pharmaceuticals, INC | $19.28 | 2020 | |
| Celgene Corporation | $13.92 | 2024 | Zeposia |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.33 | 2019 | |
| Erbe USA INC | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tsauyu Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.